Keyphrases
Cystic Fibrosis
100%
Cystic Fibrosis Foundation
19%
Cystic Fibrosis Transmembrane Conductance Regulator
18%
Forced Expiratory Volume in 1 Second (FEV1)
17%
Lung Function
13%
Lung
12%
Positron Emission Tomography
11%
Pulmonary Inflammation
11%
Phe508del
10%
Lung Transplantation
10%
Cystic Fibrosis Lung Infection
10%
Randomized Trial
10%
Randomized Double-blind
10%
Phase II Trial
10%
Pulmonary Exacerbation
9%
Placebo
8%
Bronchoalveolar Lavage
8%
Airway
8%
Lung Function Decline
7%
Healthy Volunteers
7%
F508del
7%
Once-daily
6%
Hemoptysis
6%
Genotype
6%
Dornase Alfa
6%
Hypertonic Saline
6%
Endotoxin
6%
Therapeutic Development
6%
Pulmonary Function
5%
Clinical Research
5%
Developmental Networks
5%
Decline Rate
5%
Novel Therapies
5%
Riociguat
5%
Chronic Therapy
5%
Transplant Referral
5%
Membrane Protein
5%
Elderly Women
5%
Gender Differences
5%
Long-term Safety
5%
Eosinophilic Bronchitis
5%
Barriers to Adherence
5%
Response Evaluation
5%
COVID-19
5%
Elexacaftor-tezacaftor-ivacaftor
5%
Randomized Controlled Non-inferiority Trial
5%
Clinical Phenotyping
5%
Central Nervous System Involvement
5%
Pulmonary Hyalinizing Granuloma
5%
Pandoraea
5%
Medicine and Dentistry
Cystic Fibrosis
86%
Lung
26%
Patient with Cystic Fibrosis
19%
Cystic Fibrosis Transmembrane Conductance Regulator
14%
Pneumonia
11%
Forced Expiratory Volume
10%
Patient Referral
10%
Lung Transplantation
10%
Positron Emission Tomography
10%
Diseases
8%
Placebo
8%
Clinical Trial
7%
Hemoptysis
6%
Respiratory Tract Infection
6%
Neutrophil
6%
Lung Function
6%
Fluorodeoxyglucose F 18
6%
Pathogen
6%
Volunteer
6%
Dornase Alfa
6%
Table Salt
6%
Lung Lavage
5%
Noninferiority Trial
5%
Riociguat
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Pneumothorax
5%
Sex Difference
5%
Endotoxin
5%
Granuloma
5%
Drug Therapy
5%
Infection
5%
Aspergillosis
5%
Aspergillus
5%
Elastin
5%
Bronchiolitis Obliterans
5%
Upregulation
5%
Nonsense Mutation
5%
Ataluren
5%
Antibiotics
5%
